Research map: Review of combined intravesical and urethral botulinum neurotoxin type A injection in patients with neurogenic lower urinary tract dysfunction

Back to the article

Papers in this map

  1. Botulinum toxin injections for adults with overactive bladder syndrome · James B Duthie · 2011 · 264 citations · Cited by this paper
  2. Precision bacteriophage therapy for multidrug-resistant recurrent urinary tract infections: From biological rationale to clinical translation in Taiwan · 2026 · Related
  3. Botulinum Toxin as a New Therapy Option for Voiding Disorders: Current State of the Art · Thomas Leippold · 2003 · 205 citations · Cited by this paper
  4. Therapeutic advances in Alzheimer’s disease: Current strategies and future possibilities · 2026 · Related
  5. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up · David A. Ginsberg · 2021 · 158 citations · Cited by this paper
  6. Impact of grand multiparity on cardiac diastolic function and structure: A cross-sectional study in Iraqi women · 2026 · Related
  7. The prevalence of lower urinary tract symptoms (LUTS) in Brazil: Results from the epidemiology of LUTS (Brazil LUTS) study · Roberto Soler · 2017 · 107 citations · Cited by this paper
  8. Auricular acupressure for the prevention of high-altitude illness · 2025 · Related
  9. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity · Hann‐Chorng Kuo · 2003 · 101 citations · Cited by this paper
  10. Chloride-dependent mechanisms contribute to urinary bladder smooth muscle contractility: Pharmacological and molecular evidence from rat bladder tissue · 2026 · Related
  11. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics · Hann‐Chorng Kuo · 2011 · 87 citations · Cited by this paper
  12. Targeting lipid metabolic vulnerabilities with small-molecule inhibitors in acute myeloid leukemia: Emerging insights and therapeutic opportunities · 2026 · Related
  13. Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis · Junjie Huang · 2022 · 85 citations · Cited by this paper
  14. Enhancing self-care implementation and reducing marker detachment rates in cancer radiotherapy patients through diverse nursing care strategies · 2026 · Related
  15. Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders · Yu‐Hua Lin · 2020 · 50 citations · Cited by this paper
  16. Insights into the role of the shock index and its derivatives in triage · 2026 · Related
  17. Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action · Jia‐Fong Jhang · 2016 · 43 citations · Cited by this paper
  18. Effectiveness of a theory of planned behavior-based interactive and supportive intervention on medication adherence and blood pressure control in hypertensive patients · 2026 · Related
  19. Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do? · Hann‐Chorng Kuo · 2022 · 29 citations · Cited by this paper
  20. Overall survival following whole-brain radiotherapy for brain and leptomeningeal metastases from solid tumors · 2025 · Related
  21. Lower Urinary Tract Symptoms in US Women: Contemporary Prevalence Estimates from the RISE FOR HEALTH Study · Siobhan Sutcliffe · 2024 · 29 citations · Cited by this paper
  22. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction · Yao‐Lin Kao · 2019 · 28 citations · Cited by this paper
  23. Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia · M Huang · 2016 · 26 citations · Cited by this paper
  24. Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity · Yuan‐Hong Jiang · 2018 · 25 citations · Cited by this paper
  25. Botulinum toxin for treating overactive bladder in men: A systematic review · José Carlos Truzzi · 2022 · 19 citations · Cited by this paper
  26. Urodynamic prognostic factors for large post-void residual urine volume after intravesical injection of onabotulinumtoxinA for overactive bladder · Sheng‐Mou Hsiao · 2017 · 16 citations · Cited by this paper
  27. Evaluation of the effect of 100U of Onabotulinum toxin A on detrusor contractility in women with idiopathic OAB: A multicentre prospective study · Gaetano DE RIENZO · 2021 · 12 citations · Cited by this paper
  28. Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia · Yu-Hui Huang · 2022 · 11 citations · Cited by this paper
  29. Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated · Po-Cheng Chen · 2023 · 8 citations · Cited by this paper
  30. Lower urinary tract dysfunction in the central nervous system neurogenic bladder and the real-life treatment outcome of botulinum toxin A · Hann‐Chorng Kuo · 2024 · 7 citations · Cited by this paper
  31. Nonneurogenic female bladder outlet obstruction: Conservative and medical management · Andry Perrin · 2023 · 5 citations · Cited by this paper
  32. Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection · Yao‐Lin Kao · 2022 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)